Liver therapy may cure diabetes, says study

29 March 2009

A study published in the journal Developmental Cell suggests that diabetes could be cured by causing liver cells to produce insulin.

Five years ago, researchers at the Baylor College of Medicine in Texas,  USA, found that they could cause the livers of mice with damaged  pancreases to produce insulin using neurogenin3 gene therapy. The blood  sugar of the mice then returned to normal following only one treatment,  however, the effect only lasted for six weeks.

The scientists now believe that they understand how the treatment works,  by utilizing adult stem cells to alter the liver.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight